16
Jun
2026

CHONGQING DAXIN PHARMACEUTICAL CO., LTD.

Exhibitor at CPHI & PMEC China 2026 stand E6E33, Pharma Ingredients
About Us

Chongqing Daxin Pharmaceutical Co., Ltd. is the largest manufacturing base of Lovastatin in the world with strong pharmaceutical manufacturing capability which owns advanced medical manufacturing equipments and two large-scale pharmaceutical manufacturing bases, including a new base complying with international GMP standards located in Shuitu, Liangjiang New District, Chongqing City. There are about hundred of APIs, finished dosages and intermediates, including cardio-vascular, antibiotics, immunosuppressant, plasma volume expander, and etc.

Read more Show less
Sales Markets
Show more Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
View company profile
Contact info
  • +86 023 67522635
  • Website
  • No,21. Founder Road, Shuitu Town , Beibei District, 401147, Chongqing, Yubei District, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E6E33, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • sirolimus

    Product sirolimus

  • Daptomycin

    Product Daptomycin

    Chongqing Daxin Pharmaceutical Co. Ltd. provides wide range of pharmaceutical products which includes daptomycin. It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Doramectin

    Product Doramectin

    Doramectin
  • Doramectin

    Product Doramectin

    Doramectin
  • Hydroxyethyl starch 130/0.4

    Product Hydroxyethyl starch 130/0.4

    Chongqing Daxin Pharmaceutical Co. Ltd. provides wide range of pharmaceutical products which includes hydroxyethyl starch 130/0.4. It belongs to active pharmaceutical ingredient category. Contact us for more information.